181 related articles for article (PubMed ID: 30173893)
1. Paclitaxel promotes lung cancer cell apoptosis via MEG3-P53 pathway activation.
Xu J; Su C; Zhao F; Tao J; Hu D; Shi A; Pan J; Zhang Y
Biochem Biophys Res Commun; 2018 Sep; 504(1):123-128. PubMed ID: 30173893
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
Xia Y; He Z; Liu B; Wang P; Chen Y
Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
[TBL] [Abstract][Full Text] [Related]
3. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3.
Hu D; Su C; Jiang M; Shen Y; Shi A; Zhao F; Chen R; Shen Z; Bao J; Tang W
Biochem Biophys Res Commun; 2016 Mar; 471(2):290-5. PubMed ID: 26850851
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
[TBL] [Abstract][Full Text] [Related]
7. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
Hu Z; Zeng Q; Zhang B; Liu H; Wang W
Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
[TBL] [Abstract][Full Text] [Related]
8. Involvement of endoplasmic reticulum stress and p53 in lncRNA MEG3-induced human hepatoma HepG2 cell apoptosis.
Chen RP; Huang ZL; Liu LX; Xiang MQ; Li GP; Feng JL; Liu B; Wu LF
Oncol Rep; 2016 Sep; 36(3):1649-57. PubMed ID: 27432655
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy.
Xia H; Qu XL; Liu LY; Qian DH; Jing HY
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1020-1027. PubMed ID: 29509250
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway.
Xu J; Ni L; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Aging (Albany NY); 2021 Feb; 13(4):5986-6009. PubMed ID: 33612481
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
[TBL] [Abstract][Full Text] [Related]
12. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
Chen S; Zhang Z; Zhang J
Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
[No Abstract] [Full Text] [Related]
13. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MEG3 mediated angiogenesis after cerebral infarction through regulating p53/NOX4 axis.
Zhan R; Xu K; Pan J; Xu Q; Xu S; Shen J
Biochem Biophys Res Commun; 2017 Aug; 490(3):700-706. PubMed ID: 28634073
[TBL] [Abstract][Full Text] [Related]
15. High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.
Wu JL; Meng FM; Li HJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5938-5945. PubMed ID: 30280775
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor protects bone marrow mesenchymal stem cells from hypoxia/ischemia-induced apoptosis by regulating lncRNA MEG3.
Bai Z; Hu K; Yu J; Shen Y; Chen C
J Zhejiang Univ Sci B; 2022 Dec; 23(12):989-1001. PubMed ID: 36518052
[TBL] [Abstract][Full Text] [Related]
17. Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.
Yang T; Zhang W; Wang L; Xiao C; Guo B; Gong Y; Liang X; Huang D; Li Q; Nan Y; Xiang Y; Shao J
J Int Med Res; 2019 Jan; 47(1):481-493. PubMed ID: 30556447
[TBL] [Abstract][Full Text] [Related]
18. Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163.
Su L; Han D; Wu J; Huo X
Tumour Biol; 2016 Mar; 37(3):3925-31. PubMed ID: 26482610
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway.
Li C; Zhao X; Yang Y; Liu S; Liu Y; Li X
Med Sci Monit; 2018 May; 24():2750-2757. PubMed ID: 29723165
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 in the induction of cyclooxygenase-2 by cisplatin or paclitaxel in non-small cell lung cancer cell lines.
Duarte ML; de Moraes E; Pontes E; Schluckebier L; de Moraes JL; Hainaut P; Ferreira CG
Cancer Lett; 2009 Jun; 279(1):57-64. PubMed ID: 19217709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
